Real-time enrollment status for this erythropoietic protoporphyria clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05005975 |
| Recruiting Status | Recruiting |
| Condition | Erythropoietic Protoporphyria |
| Phase | Clinical Trial |
| Target Enrollment | 301 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Mitsubishi Tanabe Pharma America Inc. |
| Last Updated on CT.gov | December 11, 2025 (Dec 11, 2025) |
As of March 2, 2026: Clinical trial NCT05005975 is currently recruiting participants. This clinical trial study for erythropoietic protoporphyria is actively seeking new participants at 15 locations across the United States. The study is sponsored by Mitsubishi Tanabe Pharma America Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05005975 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05005975 was last updated Dec 11, 2025 (December 11, 2025). HelloStudys verifies this status automatically.